Skip to content
Visnia
CtrlK
EconomyAI buildoutMarket MapFundsWatchlist
Log in
Market cap
Revenue
Net income
Cash on hand
Gross margin
Net margin
EPS
P/E ratio
Search
Market mapFundsWatchlist
Visnia

KKairos Pharma, LTD.

EconomyAI buildoutMarket MapFundsWatchlist
Log in
K

Kairos Pharma, LTD.

  • Overview
  • Financial statements
  • Metrics
  • Quarterly earnings
  • Similar companies
  • News
  • Insider Transactions

News

News

  • Kairos Pharma to Present and Moderate at Discovery on Target Conference in Boston, MA
    Sep 23, 2026Kairos Pharma, Ltd. Press Releases
  • Kairos Pharma to Present at the H.C. Wainwright 28th Annual Global Investment Conference
    Sep 9, 2026Kairos Pharma, Ltd. Press Releases
  • Kairos Pharma Announces 1-for-7 Reverse Stock Split
    Aug 21, 2026Kairos Pharma, Ltd. Press Releases
  • Kairos Pharma Announces Strategic Collaboration with Bayer to Enhance XOFIGO Activity in Metastatic Prostate Cancer
    Jul 22, 2026Kairos Pharma, Ltd. Press Releases
  • Kairos Pharma Reports Breakthrough Interim Safety Data in Phase 1 Trial of ENV-105 in EGFR-Mutated Lung Cancer Patients — Targeting a $10 Billion Drug Resistance Market
    Jul 15, 2026Kairos Pharma, Ltd. Press Releases
  • Kairos Pharma Recaps Important Acquisitions and Details Plans for the Balance of 2026 in Letter to Shareholders
    Jun 4, 2026Kairos Pharma, Ltd. Press Releases
  • Kairos Pharma Receives GHP Magazine’s Healthcare & Pharmaceutical Award
    May 14, 2026Kairos Pharma, Ltd. Press Releases
  • Kairos Pharma, Ltd. Sets Annual Meeting of Shareholder Date and Provides Update on Its Annual Filings
    May 8, 2026Kairos Pharma, Ltd. Press Releases
  • Kairos Pharma Recognized with Pinnacle Award for Excellence in Healthcare Innovation
    Apr 15, 2026Kairos Pharma, Ltd. Press Releases
  • Kairos Pharma Announces Signing of Binding Strategic Asset Acquisition of Exclusive Worldwide Rights to CL-273 From OrbiMed and Torrey Pines Investment-Backed Celyn Therapeutics
    Mar 2, 2026Kairos Pharma, Ltd. Press Releases
  • Overview
  • Financial statements
  • Metrics
  • Quarterly earnings
  • Burn Rate
  • Similar companies
  • News
  • Insider Transactions